Health knowledge made personal
Join this community!
› Share page:
Search posts:

TAS-108 to advance to phase III clinical trials

Posted Aug 24 2010 12:00am

Read more about this drug that targets advanced breast cancer, and, specifically, patients who have not had success with Tamoxifen® or aromatase inhibitors (e.g. Arimidex®). To date, through the Phase II trials, it has shown effectiveness and tolerable side effects. … Continue reading

Post a comment
Write a comment:

Related Searches